Skip to content

Effect of Yohimbine on Colon Transit

Effect of Oral Yohimbine on Colonic Transit: Randomized, Placebo-Controlled Trial

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00217048
Enrollment
30
Registered
2005-09-22
Start date
2005-06-30
Completion date
2005-10-31
Last updated
2009-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

This study is being done to learn if yohimbine, a naturally occurring drug, affects the speed at which food travels through the stomach, intestines and colon, and if yohimbine affects the amount of liquid you can drink in a short period of time. Understanding how yohimbine works on the gut may help develop new treatments for patients with constipation. Yohimbine has been approved by the Food and Drug Administration (FDA) for routine clinical use, however, its use as proposed in this study is considered investigational.

Interventions

DRUGYohimbine, oral

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Healthy male or non-pregnant, non-breastfeeding female volunteers, -18-65 years old; * Able to provide written informed consent before participating in the study; * Able to communicate adequately with the investigator and to comply with the requirements for the entire study.

Design outcomes

Primary

MeasureTime frame
Colonic transit

Secondary

MeasureTime frame
Small bowel transit time
Gastric emptying time
Maximum tolerated volume ingested during satiation testing
Average stools per day
Stool consistency

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026